Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-21

Clinical Trial Update: Efficacy of Hydroxyzine for Patients With Panic Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating hydroxyzine for panic disorder is not yet recruiting, indicating ongoing or planned post-marketing effectiveness studie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyzine (hydroxyzine)

Snippet

Sponsor: Sultan Qaboos University | Conditions: Panic Disorder | Phase 4 | Status: NOT_YET_RECRUITING